33244179|t|Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse.
33244179|a|Mucopolysaccharidosis type IIIB (MPS IIIB) is an autosomal recessive lysosomal disease caused by defective production of the enzyme alpha-N-acetylglucosaminidase. It is characterized by severe and complex central nervous system degeneration. Effective therapies will likely target early onset disease and overcome the blood-brain barrier. Modifications of adeno-associated viral (AAV) vector capsids that enhance transduction efficiency have been described in the retina. Herein, we describe for the first time, a transduction assessment of two intracranially administered adeno-associated virus serotype 8 variants, in which specific surface-exposed tyrosine (Y) and threonine (T) residues were substituted with phenylalanine (F) and valine (V) residues, respectively. A double-mutant (Y444 + 733F) and a triple-mutant (Y444 + 733F + T494V) AAV8 were evaluated for their efficacy for the potential treatment of MPS IIIB in a neonatal setting. We evaluated biodistribution and transduction profiles of both variants compared to the unmodified parental AAV8, and assessed whether the method of vector administration would modulate their utility. Vectors were administered through four intracranial routes: six sites (IC6), thalamic (T), intracerebroventricular, and ventral tegmental area into neonatal mice. Overall, we conclude that the IC6 method resulted in the widest biodistribution within the brain. Noteworthy, we demonstrate that GFP intensity was significantly more robust with AAV8 (double Y-F + T-V) compared to AAV8 (double Y-F). This provides proof of concept for the enhanced utility of IC6 administration of the capsid modified AAV8 (double Y-F + T-V) as a valid therapeutic approach for the treatment of MPS IIIB, with further implications for other monogenic diseases.
33244179	31	35	AAV8	Species	372030
33244179	94	102	MPS IIIB	Disease	MESH:D009084
33244179	103	108	mouse	Species	10090
33244179	110	141	Mucopolysaccharidosis type IIIB	Disease	MESH:D009084
33244179	143	151	MPS IIIB	Disease	MESH:D009084
33244179	159	196	autosomal recessive lysosomal disease	Disease	MESH:D016464
33244179	242	271	alpha-N-acetylglucosaminidase	Gene	27419
33244179	315	350	central nervous system degeneration	Disease	MESH:D002493
33244179	466	488	adeno-associated viral	Species	
33244179	490	493	AAV	Species	
33244179	683	716	adeno-associated virus serotype 8	Species	
33244179	823	836	phenylalanine	Chemical	MESH:D010649
33244179	845	851	valine	Chemical	MESH:D014633
33244179	897	908	Y444 + 733F	DNAMutation	tmVar:|Allele|Y,F|444_733;VariantGroup:2;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	931	942	Y444 + 733F	DNAMutation	tmVar:|Allele|Y,F|444_733;VariantGroup:2;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	945	950	T494V	ProteinMutation	tmVar:p|SUB|T|494|V;HGVS:p.T494V;VariantGroup:0;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	952	956	AAV8	Chemical	-
33244179	1022	1030	MPS IIIB	Disease	MESH:D009084
33244179	1162	1166	AAV8	Chemical	-
33244179	1412	1416	mice	Species	10090
33244179	1597	1601	AAV8	Chemical	-
33244179	1610	1613	Y-F	ProteinMutation	tmVar:p|SUB|Y||F;VariantGroup:3;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	1616	1619	T-V	ProteinMutation	tmVar:p|SUB|V||T;VariantGroup:1;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	1633	1637	AAV8	Chemical	-
33244179	1646	1649	Y-F	ProteinMutation	tmVar:p|SUB|Y||F;VariantGroup:3;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	1753	1757	AAV8	Chemical	-
33244179	1766	1769	Y-F	ProteinMutation	tmVar:p|SUB|Y||F;VariantGroup:3;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	1772	1775	T-V	ProteinMutation	tmVar:p|SUB|V||T;VariantGroup:1;OriginalGene:27419;CorrespondingGene:4669;CorrespondingSpecies:10090
33244179	1830	1838	MPS IIIB	Disease	MESH:D009084
33244179	1876	1894	monogenic diseases	Disease	MESH:D004194
33244179	Association	MESH:D009084	CorrespondingGene:4669;CorrespondingSpecies:10090;OriginalGene:27419;VariantGroup:3;tmVar:p
33244179	Negative_Correlation	CorrespondingGene:4669;CorrespondingSpecies:10090;OriginalGene:27419;VariantGroup:2;tmVar:	MESH:D009084
33244179	Association	MESH:D009084	CorrespondingGene:4669;CorrespondingSpecies:10090;OriginalGene:27419;VariantGroup:2;tmVar:
33244179	Negative_Correlation	MESH:D009084	HGVS:p.T494V;CorrespondingGene:4669
33244179	Association	MESH:D004194	CorrespondingGene:4669;CorrespondingSpecies:10090;OriginalGene:27419;VariantGroup:1;tmVar:p
33244179	Association	MESH:D009084	CorrespondingGene:4669;CorrespondingSpecies:10090;OriginalGene:27419;VariantGroup:1;tmVar:p
33244179	Association	MESH:D009084	4669
33244179	Association	MESH:D004194	4669

